Synthesis, antibacterial and antifungal activities of 3-(1,2,4-triazol-3- yl)-4-thiazolidinones

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 2, 2009, Pages 447-452

  Ozkirimli, Sumru ^a   Kazan, Fusun ^a   Tunali, Yaǧmur ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

1,2,4 Triazole; 4 thiazolidinone; Antibacterial; Antifungal

Indexed keywords

2 (3 NITROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 (3,4 DICHLOROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 (4 CHLOROPHENYL) 5 METHYL 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 (4 FLUOROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 (4 FLUOROPHENYL) 5 METHYL 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 [(4 METHOXYCARBONYL)PHENYL] 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 2 [(4 METHOXYCARBONYL)PHENYL] 5 METHYL 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 3 (1,2,4 TRIAZOL 3 YL) 4 THIAZOLIDINONE DERIVATIVE; 3 AMINO 1,2,4 TRIAZOLE DERIVATIVE; 5 METHYL 2 (2 NITROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 5 METHYL 2 (3 NITROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 5 METHYL 2 (4 NITROPHENYL) 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; 5 METHYL 2 PHENYL 3 (1H 1,2,4 TRIAZOL 3 YL) 1,3 THIAZOLIDIN 4 ONE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; PROPIONIC ACID DERIVATIVE; SCHIFF BASE; THIAZOLIDINE DERIVATIVE; THIOGLYCOLIC ACID; THIOLACTIC ACID; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; 2-MERCAPTOACETATE; THIAZOLE DERIVATIVE; THIOGLYCOLIC ACID DERIVATIVE; THIOL DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; MICROBIOLOGICAL EXAMINATION; SYNTHESIS;

STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; MICROBIAL SENSITIVITY TESTS; SCHIFF BASES; SULFHYDRYL COMPOUNDS; THIAZOLES; THIOGLYCOLATES; TRIAZOLES;

EID: 68049113518     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802188511     Document Type: Article

References (19)

1. Sun Q, Xu J, Cao Y, Zhang W, Wu Q, Zhang D, Zhang J, Zhao H, Jiang Y. Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14a-demethylase(CYP51). Eur J Med Chem 2007;42: 1226-1233.
2. Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids 2008;73: 339-347.
3. Sanati H, Belanger P, Fratti R, Ghannoum M. A new triazole, voriconazole(UK-109,496) blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 1997;41: 2492-2496.
4. Andes D. Antifungal pharmacokinetics and pharmacodynamics: Understanding the implications for antifungal drug resistance. Drug Res Updates 2004;7: 185-194.
5. Karaburun N, Benkli K, Tunali Y, Uçucu U, Demirayak S. Synthesis and antifungal activities of some aryl[3-(imidazol-1- yl/triazol-1-ylmethyl) benzofuran-2-yl]ketoximes. Eur J Med Chem 2006;41: 651-656.
6. Ozkirimli S, Apak TI, Kiraz M, Yegenoglu Y. Synthesis of new triazolyl-N,N-dialkyldithiocarbamates as antifungal agents. Arch Pharmacal Res 2005;28: 1213-1218.
7. Chevreuil F, Landreau A, Seraphin D, Larcher G, Bouchara J, Richomme PJ. Synthesis and antifungal activity of new thienyl and aryl conazoles. J Enz Inhib Med Chem 2006;21: 293-303.
8. Ur F, Cesur N, Birteksöz S, Otük G. Synthesis of some new 6-methylimidazo[2,1-b] thiazole-5-carbohydrazide derivatives and their antimicrobial activities. Arzneim-Forsch/Drug Res 2004;54: 125-129.
9. Vicini P, Gernikaki A, Anastasia K, Incerti M, Zani F. Synthesis and antimicrobial activity of novel 2-thiazolylimino- 5-arylidene-4-thiazolidinones. Bioorg Med Chem 2006;14: 3859-3864.
10. Deeb A, Bayoumy BE, El-Mobayed M. Studies on b-lactams and thiazolidinones. Part I. Synthesis and biological activity of some new triazolyl-azetidine-2-ones and 4-thiazolidine-4- ones. Egypt J Pharm Sci 1986;27: 37-41.
11. Rao A, Balzarini J, Carbone A, Chimirri A, Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappala M. Synthesis of new 2,3-diaryl-1,3- thiazolidin-4-ones as anti-HIV agents. Farmaco 2004;59: 33-39.
12. Güzel O, Terzioglu N, Capan G, Salman A. Synthesis and biological evaluation of new 5-methyl-N-(3-oxo-1-thia-4- azaspiro[4.5]-dec-4-yl)-3-phenyl- 1H-indole-2-carboxamide derivatives. Arkivoc 2006;xii: 98-110.
13. Capan G, Ulusoy N, Ergenc N, Kiraz M. New 6-phenylimidazo[ 2,1-b] thiazole derivatives: Synthesis and antifungal activity.Montsh Chem 1999;130: 1399-1407.
14. KavithaCV, Basappa S, Swamy SN,MantelinguK,Doreswamy S, Sridhar MA, Prasad JS, Rangappa KS. Synthesis of new bioactive venlafaxine analogs: Novel thiazolidin-4-ones as antimicrobials. BioorgMed Chem 2006;14: 2290-2299.
15. Barry AL, Thornsberry C. Susceptibility tests: Diffusion test procedures. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Manual of clinical microbiology. 4th ed. Washington DC: ASM; 1985. p 978-980.
16. Jones RN, Barry AL, Gavan TL,Washington JA. Susceptibility tests: Microdilution and macrodilution broth procedures. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Manual of clinical microbiology. 4th ed. Washington DC: ASM; 1985. p 972-974.
17. NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standart. 2nd ed. NCCLS document M27-A 2. Pennsylvania USA; 2002.
18. Karali N, Ilhan E, Gürsoy A, Kiraz M. New cyclohexylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of 3-phenyl-4(3H)- quinazolinones. Il Farmaco 1998;53: 346-349.
19. ErgençN, Çapan G, Günay NS, özkirimli S, Güngör M, Özbey S, Kendi E. Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5-imidazolidinedione derivatives. Arch Pharm Pharm Med Chem 1999;332: 343-347.